Loading the records…
Loading the records…
Leidos Holdings ($LDOS) received a $485M task order from NIH's National Cancer Institute for operational support through FY27. This represents ~1.6% of annual revenue, providing stable backlog growth for Leidos's health segment.
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
For Leidos Holdings, this contract provides a modest but reliable revenue stream in its health segment. Investors should view this as a positive signal of continued government demand for biomedical research support services. The stock may see incremental gains as backlog grows, but the impact is limited given Leidos's size. No major sector-wide implications are expected.
The Department of Health and Human Services, through the National Institutes of Health, awarded a $485M delivery order to Leidos Biomedical Research Inc for NCI operational task orders covering FY26-FY27. Leidos Biomedical Research is a wholly owned subsidiary of Leidos Holdings, a publicly traded technology and defense contractor. This contract is a renewal of existing support services for cancer research operations, indicating sustained government investment in biomedical research infrastructure.
For Leidos Holdings, with FY2025 revenue of $15.3B, this contract adds approximately $242.5M per year, or 1.6% of total revenue. While not transformative, it provides predictable cash flow and reinforces Leidos's relationship with NIH. Leidos's health segment, which includes biomedical research and health IT, benefits directly. The company's net margin of 1.3% in FY2025 suggests that even modest revenue additions can contribute to profitability.
No specific legislation is directly tied to this award among the provided bill signals. The contract appears to be a routine task order under existing appropriations for NIH operations. However, the broader trend of federal investment in health research supports continued demand for such services.
Potential subcontractors or supply chain beneficiaries could include smaller healthcare IT firms or research support companies, though specific names are not disclosed. Companies like IQVIA ($IQV) or Veeva Systems ($VEEV) operate in adjacent spaces but are not directly linked.
Historically, Leidos has consistently won large government task orders, and such awards typically lead to stable revenue recognition over the contract period. The stock may see modest positive sentiment as the award reinforces backlog and earnings visibility.
Matched on shared policy language across AI analyses, with ticker & timing weight
LEIDOS BIOMEDICAL RESEARCH INC: $484M Department of Health and Human Services Contract
LEIDOS BIOMEDICAL RESEARCH INC: $484M Department of Health and Human Services Contract
LEIDOS BIOMEDICAL RESEARCH INC: $826M Department of Health and Human Services Contract
LEIDOS BIOMEDICAL RESEARCH INC: $338M Department of Health and Human Services Contract
Executive orders & memoranda affecting the same sectors or companies
This proclamation reaffirms U.S. leadership in space exploration, declaring outer space open to development and permanent settlement by American citizens. It sets goals for a return to the Moon by 2028 and a future Mars mission, while emphasizing support for the commercial space industry. The action does not invoke specific legal authorities or direct new funding but signals continued policy focus on space.
The President invokes Section 232 of the Trade Expansion Act to declare that imports of robotics, industrial machinery, and their components threaten national security, and directs the Secretary of Commerce and USTR to negotiate agreements with trading partners to adjust these imports, potentially leading to tariffs or quotas within 180 days.
This proclamation initiates negotiations to adjust imports of wind turbines and their components under Section 232, citing national security concerns including cybersecurity vulnerabilities, radar interference, and grid reliability. It does not immediately impose tariffs but sets the stage for potential trade restrictions, and notes that certain wind turbine components made of aluminum, steel, or copper are already subject to existing tariffs.
Free — no credit card
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →